| Literature DB >> 35140290 |
Chih-Wei Chien1, An-Shine Chao2,3, Yao-Lung Chang4, Kuan-Ju Chen1,4, Hsiu-Huei Peng4, Yu-Ting Lin4, Angel Chao4, Shuenn-Dyh Chang4.
Abstract
To compare the frequency and clinical significance of familial and de novo chromosomal inversions during prenatal diagnosis. This was a retrospective study of inversions diagnosed prenatally in an Asian population by applying conventional GTG-banding to amniocyte cultures. Data from 2005 to 2019 were extracted from a single-center laboratory database. The types, frequencies, and inheritance patterns of multiple inversions were analyzed. Pericentric variant inversions of chromosome 9 or Y were excluded. In total, 56 (0.27%) fetuses with inversions were identified in the 15-year database of 21,120 confirmative diagnostic procedures. Pericentric and paracentric inversions accounted for 62.5% (35/56) and 37.5% of the inversions, respectively. Familial inversions accounted for nearly 90% of cases, and de novo mutation was identified in two pericentric and two paracentric cases. Inversions were most frequently identified on chromosomes 1 and 2 (16.1% of all inversions), followed by chromosomes 6, 7, and 10 (8.9% of all cases). The indications for invasive testing were as follows: advanced maternal age (67.3%), abnormal ultrasound findings (2.1%), abnormal serum aneuploidy screening (20.4%), and other indications (10.2%). The mode of inheritance was available for 67.9% of cases (38/56), with 89.5% of inversions being inherited (34/38). A slight preponderance of inheritance in female fetuses was observed. Three patients with inherited inversions opted for termination (two had severe central nervous system lesions and one had thalassemia major). Gestation continued for 53 fetuses, who exhibited no structural defects at birth or significant developmental problems a year after birth. Our study indicates that approximately 90% of prenatally diagnosed inversions involve familial inheritance, are spreading, and behave like founder effect mutations in this isolated population on an island. This finding can help to alleviate anxiety during prenatal counseling, which further underscores the importance of parental chromosomal analysis, further genetic studies, and appropriate counseling in cases where a nonfamilial inversion is diagnosed.Entities:
Mesh:
Year: 2022 PMID: 35140290 PMCID: PMC8828714 DOI: 10.1038/s41598-022-06024-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Frequencies and types of chromosomal abnormalities in second trimester amniocentesis, N = 21,120.
| Type | Number | Frequency (%) |
|---|---|---|
| Normal variant inversions | 303 | 1.43 |
| 46,XN,inv(9)(p12q13) | 237 | 1.12 |
| 46,X,inv(Y)(p11.2q11.2) | 65 | 0.31 |
| 46,X,inv(Y)(p11.2q11.2),inv(9)(p12q13) | 1 | |
| Other inversions | 56 | 0.27 |
| Numerical abnormalities | 459 | 2.17 |
| Structural aberrations | 468 | 2.22 |
| Total | 927 | 4.39 |
Figure 1Indications for second trimester amniocentesis in 21,120 patients.
Distribution of chromosome inversion.
| Chromosome | Karyotype | Number | Heredity | % of total |
|---|---|---|---|---|
| 1 | 46,XN,inv(1)(p22.3p34.1) | 1 | Paternal | 16.1 |
| 46,XN,inv(1)(p36.3q11) | 1 | De novo | ||
| 46,XN,inv(1)(p13q21) | 7 | Unknown: 5, Maternal: 2 | ||
| 2 | 46,XN,inv(2)(p11.2q13) | 5 | Unknown: 4, Paternal: 1 | 16.1 |
| 46,XN,inv(2)(p13q25) | 1 | Unknown | ||
| 46,XN,inv(2)(p21;q21) | 2 | Maternal: 1, Paternal: 1 | ||
| 46,XN,inv(2)(p25.1q31) | 1 | Maternal | ||
| 3 | 46,XN,inv(3)(q13.2q27) | 1 | Paternal | 1.8 |
| 4 | 46,XN,inv(4)(q12q21) | 1 | Paternal | 5.4 |
| 46,XN,inv(4)(p14q25) | 2 | Paternal: 2 | ||
| 5 | 46,XN,inv(5)(p12q15.1) | 1 | Unknown | 5.4 |
| 46,XN,inv(5)(q23.2q33.3) | 1 | Maternal | ||
| 46,XN,inv(5)(p13q22) | 1 | Maternal | ||
| 6 | 46,XN,inv(6)(p11.2p21.1) | 2 | Paternal: 2 | 8.9 |
| 46,XN,inv(6)(q21q25) | 1 | Paternal | ||
| 46,XN,inv(6)(p12q13) | 1 | Paternal | ||
| 46,XN,inv(6)(p21.1q15) | 1 | Maternal | ||
| 7 | 46,XN,inv(7)(q22q34) | 3 | Unknown: 2, Maternal: 1 | 8.9 |
| 46,XN,inv(7)(q22q31.3) | 2 | Maternal: 1 , Paternal: 1 | ||
| 8 | 46,XN,inv(8)(q21.2q24.1) | 1 | Maternal | 5.4 |
| 46,XN,inv(8)(q13q21.2) | 1 | Paternal | ||
| 46,XN,inv(8)(p22q22.3) | 1 | Paternal | ||
| 10 | 46,XN,inv(10)(p13q11.2) | 2 | Maternal: 2 | 8.9 |
| 46,XN,inv(10)(p11.2q22.1) | 3 | Unknown: 3 | ||
| 11 | 46,XN,inv(11)(p11.2q13) | 2 | Maternal: 2 | 5.4 |
| 46,XN,inv(11)(p11.2q12) | 1 | Unknown | ||
| 12 | 46,XN,inv(12)(q21q24.1) | 1 | De novo | 3.6 |
| 46,XN,inv(12)(p13.1q13.1) | 1 | Unknown | ||
| 13 | 46,XN,inv(13)(q21.2q22) | 1 | Paternal | 3.6 |
| 46,XN,inv(13)(q14.3q21.2) | 1 | Maternal | ||
| 14 | 46,XN,inv(14)(q22q24.3) | 1 | De novo | 1.8 |
| 16 | 46,XN,inv(16)(p13.1q11.2) | 1 | Maternal | 1.8 |
| 17 | 46,XN,inv(17)(p11.2q21.1) | 1 | De novo | 1.8 |
| 18 | 46,XN,inv(18)(q21.1q23) | 3 | Maternal: 2, Paternal: 1 | 5.4 |
| Total | 56 |
Pregnancy outcomes associated with 56 cases of chromosomal inversion.
| Factor | Number (total n = 56) | Percent |
|---|---|---|
| Pericentric | 35 | 62.5% |
| Paracentric | 21 | 37.5% |
| Maternal | 18 | 47.4% (18/38) |
| Paternal | 16 | 42.1% (16/38) |
| De novo | 4 | 10.5% (4/38) |
| Unknown | 18 | |
| Male | 25 | 44.6% |
| Female | 31 | 55.4% |
| Live birth | 53 | 94.6% |
| Elective termination | 3* | 5.4% |
| Fetal death | 0 | |
| Yes* | 2 | 3.6% |
| No | 54 | 96.4% |
*CNS defects in two and one thalassemia major.